What is BioLargo?
BioLargo, Inc. is a technology-driven company specializing in advanced solutions for critical industries including wastewater treatment, food processing, healthcare, agriculture, and oil and gas. The company's proprietary technologies, such as Advanced Oxidation System (AOS), CupriDyne, and Isan system, are designed to address complex challenges in disinfection, water purification, and odor control. BioLargo markets a range of commercial, household, and personal care products under brands like Odor-No-More, Natures Best Solution, Deodorall, and NBS, demonstrating a broad application of its core innovations. Founded in 1989 and based in Westminster, BioLargo is positioned to leverage its diverse technological portfolio for significant market impact.
How much funding has BioLargo raised?
BioLargo has raised a total of $7.2M across 9 funding rounds:
Debt
$681K
Debt
$1.1M
Debt
$978K
Debt
$1.1M
Debt
$700K
Debt
$862K
Debt
$150K
Private Equity
$887K
Debt (2009): $681K, investors not publicly disclosed
Debt (2010): $1.1M, investors not publicly disclosed
Debt (2011): $978K, investors not publicly disclosed
Debt (2012): $1.1M, investors not publicly disclosed
Debt (2013): $700K, investors not publicly disclosed
Debt (2013): $862K, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Private Equity (2026): $887K, investors not publicly disclosed
What's next for BioLargo?
The substantial enterprise-level funding and recent strategic investment indicate BioLargo is poised for accelerated scaling and market penetration. This capital infusion will likely fuel further research and development, expansion of manufacturing capabilities, and broader commercialization efforts across its target industries. The company's focus on essential sectors such as water treatment and healthcare suggests a strategic direction aimed at addressing pressing global needs, positioning BioLargo for sustained growth and technological leadership.
See full BioLargo company page
